Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Into Patients With Multiple Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01453764
Recruitment Status : Withdrawn (company dissolved)
First Posted : October 18, 2011
Last Update Posted : September 1, 2017
Sponsor:
Information provided by (Responsible Party):
Ageless Regenerative Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : December 2018
Estimated Study Completion Date : April 2019